DFE Pharma logo

We are DFE Pharma

DFE Pharma is the pharmaceutical ingredient expert that has knowledge about drug delivery technology and access to a broad set of products and services for drug development.

We develop, produce and supply excipients for use in oral solid dose and inhalation formulations, but as a supplier of complete solutions we do a lot more than that. With our drug delivery platform we support global conventional pharma companies, next generation biopharma innovators and the nutraceutical health industry, which makes us the partner of choice across healthcare.

We understand and rise to the healthcare needs and challenges of our customers. We have a robust business that mitigates risk for customers at every level, and pioneer innovative drug delivery technologies. We are a partner, as much as a pioneer. We work with your future in mind.

Oral solid dose

Most medicines, from over the counter treatments to prescription drugs, are taken by mouth in the form of tablets and capsules. Oral medicines are convenient, flexible and cost-effective. They can be produced in large numbers very fast (production rates of 1 million per hour can be achieved). Variants that are precisely suited to individual preferences and needs can easily be developed.

Dry powder inhalation

As a leader in the field of Inhalation, DFE Pharma offers the pharmaceutical industry the most optimal solution for the development of their Dry Powder Inhalation (DPI) drug. DFE Pharma is a partner for pharmaceutical companies developing drugs for pulmonary delivery for many years. We offer a wide range of standard products, plus the option to customize our products to meet your specific needs.

DFE Pharma

Transistorweg 5 (Buidling M)

6534 AT Nijmegen




More companies in this area

Pleco Therapeutics

Our current pre-clinical development programs focus on the development of treatments for Acute Myeloid Leukaemia (AML), a relatively rare blood cancer, and Small-Cell Lung Cancer (SCLC), an aggressive subtype of lung cancer.

GCP-Service International

GCP-Service International is a mid-size contract research organization (CRO), with branches across Germany, Netherlands, Poland and Czech Republic.


Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases.


TropIQ Health Sciences offers laboratory screening services for the discovery and development of drugs against malaria.

Protinhi Therapeutics

Protinhi Therapeutics is an early stage biotech company, developing novel drugs against diseases with a high unmet medical need using proprietary technology and compounds that target diseases via Protease Inhibition. The focus of Protinhi is on upcoming viral threats and particularly on Dengue and Zika.

Okklo Life Sciences

Okklo Life Sciences is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies, with a focus on neglected and orphan diseases.

Settle at Novio Tech Campus!

Connect with Novio Tech Campus!